Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Amgen to reduce price of its cholesterol drug Repatha starting 2020Amgen to reduce price of its cholesterol drug Repatha starting 2020
    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trialBristol-Myers Opdivo, Yervoy show promise in lung cancer trial
    SHOCKING: Pharmacist arrested for allegedly molesting woman inside medical storeSHOCKING: Pharmacist arrested for allegedly molesting woman inside medical store
    Andhra Pradesh: Blast at Chemist shop, 2 deadAndhra Pradesh: Blast at Chemist shop, 2 dead
    Lupin gets USFDA nod for generic version of Levoxyl tablets to treat hypothyroidismLupin gets USFDA nod for generic version of Levoxyl tablets to treat hypothyroidism
    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observationsAlkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations
    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDATests indicate heartburn drug Zantac does not form carcinogen in users: USFDA
    Revenue from operations stood at Rs 2005 crore in Q2: Torrent PharmaRevenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma
    Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trialMirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial
    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percentLandmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent
    Cadila Healthcare gets EIR from USFDA for Baddi facilityCadila Healthcare gets EIR from USFDA for Baddi facility
    Boehringer Ingelheim, The Defeat-NCD Partnership join hands to fight non-communicable diseasesBoehringer Ingelheim, The Defeat-NCD Partnership join hands to fight non-communicable diseases
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok